mk 0591 has been researched along with Hyperoxia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, KE; Lee, C; Namgung, R; Park, MS; Sohn, MH | 1 |
| Boros, V; Burghardt, JS; Morgan, CJ; Olson, DM | 1 |
| Leung, WI; Manji, JS; O'Kelly, CJ; Olson, DM | 1 |
3 other study(ies) available for mk 0591 and Hyperoxia
| Article | Year |
|---|---|
5-Lipoxygenase-activating protein (FLAP) inhibitor MK-0591 prevents aberrant alveolarization in newborn mice exposed to 85% oxygen in a dose- and time-dependent manner.
Topics: 5-Lipoxygenase-Activating Protein Inhibitors; 5-Lipoxygenase-Activating Proteins; Animals; Animals, Newborn; Body Weight; Bronchopulmonary Dysplasia; Disease Models, Animal; Dose-Response Relationship, Drug; Humans; Hyperoxia; Indoles; Infant, Newborn; Injections, Subcutaneous; Mice; Oxygen; Pulmonary Alveoli; Quinolines; Time Factors | 2011 |
Leukotrienes are indicated as mediators of hyperoxia-inhibited alveolarization in newborn rats.
Topics: Acute Disease; Animals; Animals, Newborn; Arachidonate 5-Lipoxygenase; Body Weight; Female; Hyperoxia; In Vitro Techniques; Indoles; Leukotrienes; Lipoxygenase Inhibitors; Lung; Lung Injury; Male; Naphthaleneacetic Acids; Pulmonary Alveoli; Quinolines; Rats; Rats, Sprague-Dawley; Time Factors | 1997 |
Timing of hyperoxic exposure during alveolarization influences damage mediated by leukotrienes.
Topics: Age Factors; Animals; Animals, Newborn; Cell Division; Female; Hyperoxia; Indoles; Leukotrienes; Lipoxygenase Inhibitors; Male; Oxygen; Pulmonary Alveoli; Quinolines; Rats; Rats, Sprague-Dawley | 2001 |